Brazil’s integrated platform uniting Simbiose, Bioma, Biagro, Biograss, and Biojet combines industrial scale, R&D excellence, and application technology to drive the next phase of global biological innovation.

Brazil has established the world’s largest integrated biological inputs ecosystem, bringing together five commercial brands, four industrial units, exclusive technologies, and a dedicated research center under a single platform. The Cogny ecosystem represents a new model for the biological crop protection sector — a “one-stop solution” addressing agriculture’s growing demand for sustainability and innovation.

Luiz Felipe Fiorese

“Cogny is the largest ecosystem dedicated to agricultural microbiology in the world today,” said Luiz Felipe Fiorese, International Business Manager at Cogny. “These are companies 100% focused on delivering biological solutions in inputs, application equipment, and seeds with embedded technology, plus our own research center.”

INSIDE THE ECOSYSTEM

At the commercial core are Simbiose, Bioma, and Biagro — each serving distinct markets across Latin America and together holding nearly 300 registered technologies. Simbiose operates field teams in Paraguay, while Biagro has over 20 years of presence in Argentina. In Bolivia and Uruguay, both Simbiose and Bioma serve local markets through a multi-brand approach.

Specialized units add further capability: Biojet manufactures field application equipment with advanced temperature control and a self-cleaning nozzle system, while Biograss develops seeds with embedded biological technology to enhance soil health and structure.

INDUSTRIAL CAPACITY MEETS INNOVATION

Cogny operates the largest microbiological production complex in global agribusiness — four manufacturing units (three in Brazil, one in Argentina) capable of producing bacteria, viruses, and fungi within a single corporate structure. Its total capacity exceeds 40 million kilos/liters per year, set to expand to 60 million, supported by 17 distribution centers nationwide. “Having all three biological categories in one group allows us to offer complete solutions — a true one-stop shop for producers, cooperatives, and B2B partners,” noted Fiorese.

The company’s industrial strength was forged in Brazil’s large-scale soybean and corn sectors, where conditions demand robust, shelf-stable formulations requiring no refrigeration.

SCIENCE AT THE CORE

R&D efforts are centered at Orygen Research, Brazil’s largest private microbiological research and innovation hub focused on agribusiness. Holding an NB-2 biosafety certification from CTNBio, Orygen manages every stage from microorganism bioprospecting to industrial-scale formulation. With over 15 years of experience, it develops technologies exclusively for companies within the Cogny ecosystem.

EXPANDING GLOBALLY

Cogny’s international growth strategy adapts to regional realities. In distant markets, it builds licensing and distribution partnerships, such as a recent agreement with Corteva for the European Union. In familiar regions — including the Americas and Africa — it operates directly through field teams and hybrid distribution models.

“Our approach depends on the dynamics of each market,” said Fiorese. “We aim to build revenue streams in stable currencies and make exports a major share of our business.”

SHOWCASED AT ABIM 2025

Cogny showcased its integrated capabilities at ABIM 2025, the world’s largest biological pest and disease control event, held October 20–22 in Basel, Switzerland. While previous ABIM editions featured participation mainly through the Simbiose brand, this year Cogny presented the entire ecosystem, marking a new phase in its international positioning.

Analysts forecast that biological solutions will represent nearly 25% of global crop protection within the next decade. According to DunhamTrimmer – International Bio Intelligence Agency, Brazil already generates over US$1.5 billion in bioinputs revenue and is expected to surpass US$3 billion by 2030.